Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Monocytic Expression of Heme Oxidase-1 (HO-1) in Sickle Cell Patients and Correlation With the Humoral Immune Response to Vaccine and With Allo-immunization

NCT03111589 is registered in ClinicalTrials.gov with Francis Corazza as lead sponsor.

NCT NCT03111589
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03111589 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Monocytic Expression of Heme Oxidase-1 (HO-1) in Sickle Cell Patients and Correlation With the Humoral Immune Response to Vaccine and With Allo-immunization
Lead sponsor
Francis Corazza
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2016
Completion date
October 31, 2018
Enrollment
102 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

sickle cell disease